Variant report

Variant	esv2830157
Chromosome Location	chr6:27634640-27657647
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:100)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:100 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:27636299..27636853-chr6:27655225..27655832,2	K562	blood:
2	chr6:27637832..27638430-chr6:27654490..27655382,2	K562	blood:
3	chr6:27634865..27637483-chr6:27858209..27861197,3	K562	blood:
4	chr6:27636452..27637996-chr6:27722273..27724766,2	K562	blood:
5	chr6:27486558..27487262-chr6:27654877..27655530,2	MCF-7	breast:
6	chr6:27644939..27650269-chr6:27651814..27657274,7	K562	blood:
7	chr6:27099860..27102735-chr6:27633171..27635256,2	K562	blood:
8	chr6:27646424..27648439-chr6:27863200..27865949,2	K562	blood:
9	chr6:27572241..27575123-chr6:27648524..27650391,2	K562	blood:
10	chr6:27114783..27117247-chr6:27654285..27656648,2	K562	blood:
11	chr6:27641556..27643380-chr6:27775073..27777915,2	K562	blood:
12	chr6:27114631..27116159-chr6:27636447..27639406,2	K562	blood:
13	chr6:27636377..27638707-chr6:28318162..28320333,2	K562	blood:
14	chr6:27559025..27560718-chr6:27653331..27656285,2	K562	blood:
15	chr6:27264234..27265943-chr6:27637252..27639333,2	K562	blood:
16	chr6:27640023..27641609-chr6:27744727..27746412,2	K562	blood:
17	chr6:27585302..27586142-chr6:27655326..27655973,2	K562	blood:
18	chr6:27652252..27653760-chr6:27657291..27659495,2	MCF-7	breast:
19	chr6:27636112..27637828-chr6:27637904..27639437,2	K562	blood:
20	chr6:27634605..27637879-chr6:27644998..27648332,4	K562	blood:
21	chr6:27638628..27643322-chr6:27645901..27648389,5	K562	blood:
22	chr6:27638059..27640499-chr6:27771985..27774359,2	MCF-7	breast:
23	chr6:27656124..27658141-chr6:27861315..27864462,3	K562	blood:
24	chr6:27114095..27116551-chr6:27640385..27641956,2	K562	blood:
25	chr6:27521716..27523597-chr6:27638518..27641412,2	K562	blood:
26	chr6:27652290..27655444-chr6:27857919..27861967,3	K562	blood:
27	chr6:27632657..27637879-chr6:27644957..27648332,5	K562	blood:
28	chr6:27635615..27637908-chr6:27648456..27651146,2	K562	blood:
29	chr6:27635575..27638134-chr6:27861679..27863418,2	K562	blood:
30	chr6:27651170..27656145-chr6:27660253..27663653,4	MCF-7	breast:
31	chr6:27655233..27656837-chr6:27693147..27694855,2	K562	blood:
32	chr6:27635489..27641593-chr6:27648456..27655439,10	K562	blood:
33	chr6:27636305..27638442-chr6:27804240..27806854,2	K562	blood:
34	chr6:27102022..27104222-chr6:27640274..27641905,2	K562	blood:
35	chr6:27638628..27643322-chr6:27645901..27648389,5	K562	blood:
36	chr6:27634605..27637879-chr6:27644998..27648332,4	K562	blood:
37	chr6:27104177..27107088-chr6:27654712..27657071,2	K562	blood:
38	chr6:26157578..26160001-chr6:27646646..27649152,2	MCF-7	breast:
39	chr6:27655233..27657099-chr6:27693355..27695720,2	K562	blood:
40	chr6:27630640..27633074-chr6:27634485..27635995,2	K562	blood:
41	chr6:27585095..27585874-chr6:27654939..27655471,2	MCF-7	breast:
42	chr6:27642885..27644843-chr6:27650886..27653382,2	K562	blood:
43	chr6:27632657..27637879-chr6:27644957..27648332,5	K562	blood:
44	chr6:27155324..27157508-chr6:27634451..27636223,2	K562	blood:
45	chr6:27653789..27659338-chr6:27659392..27663401,13	K562	blood:
46	chr6:27570023..27571795-chr6:27634776..27636540,2	K562	blood:
47	chr6:27649669..27653830-chr6:27777087..27779964,4	K562	blood:
48	chr6:27598632..27599274-chr6:27655396..27655916,2	K562	blood:
49	chr6:27655370..27657742-chr6:27715050..27717959,2	K562	blood:
50	chr6:27635489..27641593-chr6:27648456..27655439,10	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HIST1H2BL-1	chr6:27634762-27635538	XLOC_005659
2	lnc-HIST1H2BL-1	chr6:27635774-27635927	XLOC_005659

No data

Variant related genes	Relation type
ENSG00000198339	chromatin interactions
ENSG00000196787	chromatin interactions
ENSG00000238648	chromatin interactions
ENSG00000158373	chromatin interactions
ENSG00000203813	chromatin interactions
ENSG00000184825	chromatin interactions
ENSG00000233224	chromatin interactions
ENSG00000265565	chromatin interactions
ENSG00000233822	chromatin interactions
ENSG00000196747	chromatin interactions
ENSG00000196331	chromatin interactions
ENSG00000182611	chromatin interactions
ENSG00000238610	chromatin interactions
ENSG00000196374	chromatin interactions
ENSG00000184348	chromatin interactions
ENSG00000216915	chromatin interactions
ENSG00000185130	chromatin interactions
ENSG00000124635	chromatin interactions
ENSG00000197903	chromatin interactions
ENSG00000197153	chromatin interactions

Extended variants
information (count: 973 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:973 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6917366	chr6:27634640-27634641	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs189588160	chr6:27634670-27634671	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs146183807	chr6:27634750-27634751	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs139064469	chr6:27634752-27634753	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs142260016	chr6:27634753-27634754	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs376474690	chr6:27634812-27634813	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
7	rs146389239	chr6:27634849-27634850	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
8	rs546563827	chr6:27634876-27634877	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
9	rs555524513	chr6:27634923-27634924	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
10	rs9380001	chr6:27634927-27634928	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs370227127	chr6:27634952-27634953	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
12	rs540856342	chr6:27635000-27635001	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
13	rs148567148	chr6:27635040-27635041	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
14	rs568627813	chr6:27635100-27635101	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
15	rs182006558	chr6:27635112-27635113	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
16	rs543733772	chr6:27635131-27635132	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
17	rs562507958	chr6:27635159-27635160	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
18	rs570528773	chr6:27635221-27635222	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
19	rs187260479	chr6:27635258-27635259	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
20	rs531617748	chr6:27635322-27635323	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
21	rs548229391	chr6:27635332-27635333	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
22	rs374324220	chr6:27635392-27635393	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
23	rs191996149	chr6:27635450-27635451	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
24	rs78339609	chr6:27635482-27635483	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
25	rs557633269	chr6:27635495-27635496	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
26	rs571057024	chr6:27635508-27635509	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
27	rs182865365	chr6:27635550-27635551	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs573015824	chr6:27635574-27635575	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs539731640	chr6:27635612-27635613	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs151073240	chr6:27635621-27635622	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs569644756	chr6:27635661-27635662	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs535450348	chr6:27635694-27635695	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs28399157	chr6:27635706-27635707	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs572165641	chr6:27635732-27635733	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs534741580	chr6:27635774-27635775	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	6 gene(s)	Overlapped CNVs	n/a
36	rs557651775	chr6:27635803-27635804	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	6 gene(s)	Overlapped CNVs	n/a
37	rs116591302	chr6:27635832-27635833	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	6 gene(s)	Overlapped CNVs	n/a
38	rs144670811	chr6:27635903-27635904	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	6 gene(s)	Overlapped CNVs	n/a
39	rs371792627	chr6:27635912-27635913	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	6 gene(s)	Overlapped CNVs	n/a
40	rs540484660	chr6:27635985-27635986	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs575988632	chr6:27635986-27635987	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs186281750	chr6:27636039-27636040	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs561972002	chr6:27636040-27636041	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs527762393	chr6:27636071-27636072	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs530114589	chr6:27636081-27636082	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs368019689	chr6:27636112-27636113	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs547906967	chr6:27636120-27636121	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs190213076	chr6:27636128-27636129	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs182805349	chr6:27636161-27636162	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs111988362	chr6:27636171-27636172	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
Bipolar disorder	19114987	CNVD

Chromatin state (count:1069 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:27633400-27635200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr6:27634600-27634800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
3	chr6:27634600-27634800	Enhancers	A549	lung
4	chr6:27634600-27634800	Enhancers	HepG2	liver
5	chr6:27634600-27634800	Enhancers	NHEK	skin
6	chr6:27634600-27635000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr6:27634600-27635600	Flanking Active TSS	K562	blood
8	chr6:27634600-27638400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
9	chr6:27634600-27640800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr6:27634800-27635000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
11	chr6:27634800-27635000	Bivalent/Poised TSS	Primary T cells from cord blood	blood
12	chr6:27634800-27635000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr6:27634800-27635000	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr6:27634800-27635000	Flanking Active TSS	HepG2	liver
15	chr6:27634800-27635200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr6:27634800-27635200	Flanking Active TSS	A549	lung
17	chr6:27634800-27635200	Active TSS	HMEC	breast
18	chr6:27634800-27635400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
19	chr6:27634800-27635800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
20	chr6:27634800-27635800	Flanking Active TSS	GM12878-XiMat	blood
21	chr6:27634800-27636200	Flanking Active TSS	NHEK	skin
22	chr6:27634800-27637600	Active TSS	H9 Cell Line	embryonic stem cell
23	chr6:27634800-27638400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
24	chr6:27634800-27638400	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr6:27634800-27638800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr6:27634800-27639400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
27	chr6:27634800-27640000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
28	chr6:27634800-27641400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
29	chr6:27635000-27635200	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr6:27635000-27635200	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr6:27635000-27635200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr6:27635000-27635200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr6:27635000-27635200	Bivalent Enhancer	Brain Cingulate Gyrus	brain
34	chr6:27635000-27635200	Bivalent Enhancer	Fetal Intestine Large	intestine
35	chr6:27635000-27635200	Enhancers	Hela-S3	cervix
36	chr6:27635000-27635200	Bivalent Enhancer	HUVEC	blood vessel
37	chr6:27635000-27635200	Bivalent Enhancer	NH-A	brain
38	chr6:27635000-27635400	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr6:27635000-27635400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
40	chr6:27635000-27635400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
41	chr6:27635000-27635400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr6:27635000-27635400	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
43	chr6:27635000-27635400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr6:27635000-27635400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
45	chr6:27635000-27635400	Flanking Bivalent TSS/Enh	HepG2	liver
46	chr6:27635000-27635400	Bivalent/Poised TSS	Osteobl	bone
47	chr6:27635000-27635600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
48	chr6:27635000-27635600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr6:27635000-27635800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr6:27635000-27636800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links